Biotech

All Articles

Kairos goes public with $6M IPO to finance tests of cancer medicine

.Along with a triad of biotechs reaching the Nasdaq on Friday, it was effortless to skip a smaller-s...

Vaccine and also Keytruda combination reliable in squamous cell carcinoma

.Immune system gate inhibitors are actually the superheroes of cancer cells treatment. Medicines lik...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Regeneron's Opdualag competitor shows 57% feedback cost

.Regeneron is actually back with lasting consequence for its LAG-3 inhibitor and PD-1 inhibitor comb...

AstraZeneca messages data on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early look at the performance of its own in-house antibod...

iTeos- GSK's TIGIT star presents purposeful enhancement

.After introducing a period 3 launch based upon favorable midstage end results, iTeos and also GSK a...

More collective FDA can easily increase uncommon illness R&ampD: record

.The FDA needs to be even more open as well as collaborative to release a surge in commendations of ...

Zenas, MBX, Bicara head to Nasdaq in warm day for biotech IPOs

.It's an unusually active Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara R...

Atea's COVID antiviral stops working to halt hospital stays in period 3

.Atea Pharmaceuticals' antiviral has actually failed yet another COVID-19 test, but the biotech stil...

Neurocrine's quote to conserve schizophrenia possibility neglects

.Neurocrine Biosciences' schizophrenia program pivot has actually failed. The biotech was unable to ...